Fundz

Centry Pharma, Inc. reported raising $11.3 Million in an initial SEC Form D filing, from an offering of $11.3 Million

PRIVATEJul 19, 2021

Amount Raised

$11.3 Million

$11.3 Million sold, per SEC Form D (first sale Jul 19, 2021)

Round Type

Venture

PhiladelphiaManufacturingBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

Century Therapeutics raised $11.3 Million in a funding round, dated July 19, 2021. Century Therapeutics is based in Philadelphia, Pennsylvania, United States.

How much did Century Therapeutics raise?
Century Therapeutics raised $11.3 Million in a funding round on July 19, 2021.
What does Century Therapeutics do?
Century Therapeutics (NASDAQ: IPSC) is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of first-generation cell..
Where is Century Therapeutics based and how big is it?
Century Therapeutics is based in Philadelphia, Pennsylvania, United States.
Who are the decision-makers at Century Therapeutics?
Fundz holds 1 contact at Century Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Century Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Aarvik Therapeutics raised $8.3M on September 2, 2021.
  • Os Therapies raised $1M on September 1, 2021.
  • PharmaCyte Biotech, Inc. raised $70M on September 1, 2021.
  • ADARx Pharmaceuticals, Inc. raised $75M on August 17, 2021.
  • Edwards Lifesciences raised $100K (Pre-Seed) on July 27, 2021.
  • Amylyx Pharmaceuticals raised $135M (Series C) on July 20, 2021.

Who to call at Century Therapeutics, and when

A new round usually means Century Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Century Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Century Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Century Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Century Therapeutics

Location

1 BRIDGE PLAZA

Philadelphia, Pennsylvania, United States

About

Century Therapeutics (NASDAQ: IPSC) is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of first-generation cell therapies. Our genetically engineered, iPSC-derived iNK and iT cell product candidates are designed to specifically target hematologic and solid tumor cancers. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of cancer care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Century Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts1 person is listed at Century Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Century Therapeutics's next move

See what Strategic adds

Century Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.